Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Paul M. Popernack"'
Autor:
Nancy J Sullivan, Thomas W Geisbert, Joan B Geisbert, Devon J Shedlock, Ling Xu, Laurie Lamoreaux, Jerome H H V Custers, Paul M Popernack, Zhi-Yong Yang, Maria G Pau, Mario Roederer, Richard A Koup, Jaap Goudsmit, Peter B Jahrling, Gary J Nabel
Publikováno v:
PLoS Medicine, Vol 3, Iss 6, p e177 (2006)
Ebola virus causes a hemorrhagic fever syndrome that is associated with high mortality in humans. In the absence of effective therapies for Ebola virus infection, the development of a vaccine becomes an important strategy to contain outbreaks. Immuni
Externí odkaz:
https://doaj.org/article/58829cdaa1924306b3ac4ae365094197
Autor:
Dennis R. Burton, Nancy J. Sullivan, Devon J. Shedlock, James M. Cunningham, Paul M. Popernack, Michael Bailey
Publikováno v:
Virology
Human Ebola virus (EBOV) causes severe hemorrhagic fever disease with high mortality and there is no vaccine or treatment. Antibodies in survivors occur early, are sustained, and can delay infection when transferred into nonhuman primates. Monoclonal
Autor:
Robert A. Schlegel, Shigeki Tsutsui, Andrew J. Henderson, Paul M. Popernack, Melissa K. Callahan, Linh T. Truong
Publikováno v:
The Journal of Immunology. 170:4840-4845
HIV-1 is an enveloped retrovirus that acquires its outer membrane as the virion exits the cell. Because of the association of apoptosis with the progression of AIDS, HIV-1-infected T cells or macrophages might be expected to express elevated levels o
Autor:
Mario Roederer, Laurie Lamoreaux, Paul M. Popernack, Zhi Yong Yang, Thomas W. Geisbert, Jerome Custers, Joan B. Geisbert, Richard A. Koup, Ling Xu, Peter B. Jahrling, Gary J. Nabel, Maria G. Pau, Jaap Goudsmit, Nancy J. Sullivan, Devon J. Shedlock
Publikováno v:
PLoS Medicine
PLoS medicine, 3(6). Public Library of Science
PLoS Medicine, Vol 3, Iss 6, p e177 (2006)
PLoS medicine, 3(6). Public Library of Science
PLoS Medicine, Vol 3, Iss 6, p e177 (2006)
Background Ebola virus causes a hemorrhagic fever syndrome that is associated with high mortality in humans. In the absence of effective therapies for Ebola virus infection, the development of a vaccine becomes an important strategy to contain outbre
Autor:
Hua-Xin Liao, Richard M. Scearce, Mille McAdams, Jae-Sung Yu, Barton F. Haynes, Aren E. Gerdon, Brian J. Huffman, David W. Wright, Paul M. Popernack, S. Munir Alam, Gary J. Nabel, Nancy J. Sullivan, David E. Cliffel
Publikováno v:
Journal of virological methods. 137(2)
Ebola virus (EBOV) Zaire, Sudan, as well as Ivory Coast are virulent human EBOV species. Both polyclonal and monoclonal antibodies (MAbs) were developed against soluble EBOV envelope glycoprotein (GP) for the study of EBOV envelope diversity and deve
Publikováno v:
Journal of hematotherapystem cell research. 10(5)
CCAAT/enhancer binding proteins (C/EBP) have been demonstrated to impact directly the development of multiple hematopoietic lineages. However, the role of C/EBPbeta in the differentiation of various hematopoietic lineages has not been thoroughly exam